What Happened in the Stock Market Today
On a day when the indexes were mostly flat, PepsiCo stock fell on earnings and Arena Pharmaceutic...
A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.
Key Data Points
Primary metrics and data points about Arena Pharmaceuticals.| Current Price: | $24.34 |
| Prev Close: | $24.05 |
| Open: | $24.15 |
| Bid: | $24.35 |
| Ask: | $24.60 |
| Day's Range: | $23.86 - $24.55 |
| 52wk Range: | $11.30 - $27.86 |
| Volume: | 1,014,860 |
| Avg Vol | 1,780,915 |
| Market Cap: | $773M |
| P/E (ttm): | -2.67 |
| EPS (ttm): | ($9.00) |
| Div & Yield: | $0.00 (0.0%) |
Company Rating
What our community thinks about Arena Pharmaceuticals.
CAPS Rating
CAPS All Stars
Powered by 
CEO Rating
The single most important factor in a company's success is the team that's leading the company.Amit Munshi, CEO
-100% Approve
Based on 4 Ratings
Business Summary
Industry, sector and description for Arena Pharmaceuticals.A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Drug Makers